CDG Invest Growth invests in the capital of companies in Morocco and Africa

CDG Invest Growth exits Steripharma, a pharmaceutical business in Morocco

CDG Invest Growth announced its exit from Laboratoires Steripharma, a well-established pharmaceutical business in Morocco through a strategic sale.

Steripharma was founded in 1999 and has since developed a large portfolio of drugs with strong recognition among patients and practitioners. The Company has its own range of medicines (generics) and also produces/distributes drugs under license for leading international laboratories. Its product range covers major therapeutic areas, including infectiology and parasitology, cardiology, respiratory system, digestive system, dental care, ophthalmology and dermatology.

Click here for more information about Steripharma

With an investment return of 3.3 money multiple, CDG Invest Growth has announced its total exit from Jet Contractors through a sale of shares on the Casablanca Stock Exchange. “CDG Invest Growth has contributed to the organic and structural development of Jet Contractors and has supported its integration of the value chain to become one […]

CDG Invest Growth has signed an agreement to acquire a stake in Société Nouvelle des Conduites d’Eau (SNCE), alongside other co-investors. SNCE is a Moroccan water equipment and hydraulic projects company. The founding Laraqui family will remain SNCE’s key shareholder. The transaction remains subject to customary regulatory approvals. Founded in 1961, SNCE operates across the […]

CDG Invest Growth, a leading Morocco based private equity firm, invests in Soludia Maghreb, the leading provider of haemodialysis products and other related drugs in Morocco, through the acquisition of a significant minority stake. Founded in 1998 by Dr Abdelaziz Razkaoui after a successful technology transfer from Soludia France, Soludia Maghreb has become a leader […]